GO:0043065 positive regulation of apoptotic process: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043065 (positive regulation of apoptotic process) describes any process that activates or increases the frequency, rate or extent of cell death by apoptotic process [1, 2, 3].
• Pro-apoptotic signaling is controlled by a balance of BCL-2 family proteins, caspases, ubiquitin-proteasome components, and transcription factors such as AP-1 and p53 [2, 6].
• Dysregulated positive regulation of apoptosis contributes to cancer, neurodegeneration, and hematological malignancies [3, 4, 8].
• Key experimental models include CRISPR knockout, point mutation, knock-in, and overexpression cell lines to dissect causal roles of apoptotic regulators [1, 4, 6].
• Methods such as flow cytometry, caspase activity assays, and transcriptomics are standard for quantifying apoptotic rate changes [3, 7].
• EDITGENE provides CRISPR cell model services and library screening to study positive regulation of apoptotic process in disease contexts [1, 4, 6].
Description
Apoptosis is a genetically programmed form of cell death essential for development, tissue homeostasis, and immune defense. The Gene Ontology term GO:0043065, positive regulation of apoptotic process, captures any molecular event that activates or increases the frequency, rate, or extent of apoptosis [1, 2, 3]. This term is critical for researchers because shifts in pro-apoptotic signaling underlie cancer resistance, autoimmune disorders, and neurodegenerative diseases [3, 4, 8]. Understanding which genes and pathways positively regulate apoptosis enables targeted therapeutic strategies and robust experimental models [2, 6]. The QuickGO definition states: Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. This article synthesizes published literature on the mechanisms, key genes, disease links, and research methods for studying GO:0043065, with a focus on CRISPR-based approaches for functional validation [1, 4, 6].
positive regulation of apoptotic process At A Glance
| GO ID | GO:0043065 |
|---|---|
| GO term | positive regulation of apoptotic process |
| Ontology | biological_process |
| Definition | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| Synonyms | activation of apoptosis; positive regulation of apoptosis; pro-apoptosis; stimulation of apoptosis; up regulation of apoptosis; up-regulation of apoptosis; upregulation of apoptosis |
| Major function | Promotes execution of programmed cell death via caspase activation, mitochondrial permeabilization, and transcriptional control [2, 3, 6]. |
| Related processes | Apoptotic signaling pathway; regulation of cell death; intrinsic and extrinsic apoptotic pathways [3, 6]. |
| Key regulators | BCL-2 family proteins, caspases, AP-1 transcription factors, ubiquitin-proteasome system components [2, 6]. |
What Is GO:0043065?
GO:0043065, positive regulation of apoptotic process, refers to any biological process that activates or increases the frequency, rate, or extent of cell death by apoptotic process. It encompasses molecular events that promote the execution of apoptosis, including activation of caspases, mitochondrial outer membrane permeabilization, and transcriptional upregulation of pro-apoptotic factors [2, 3, 6].
Why Is positive regulation of apoptotic process Important in Cell Biology?
Positive regulation of apoptotic process is fundamental to understanding how cells commit to death under physiological and pathological conditions. Its dysregulation is a hallmark of cancer, where apoptosis evasion promotes tumor survival, and of neurodegenerative diseases, where excessive apoptosis leads to neuronal loss [3, 4, 8]. Moreover, therapeutic strategies often aim to modulate this process, making it a central focus for drug discovery and CRISPR-based functional genomics [1, 6].
• Cancer: Evasion of apoptosis is a hallmark; restoring positive regulation can sensitize tumors to therapy [3, 4].
• Neurodegeneration: Excessive apoptosis contributes to neuronal loss in conditions such as glioma progression.
• Hematological malignancies: Cytotoxic agents modulate apoptotic pathways, influencing treatment response.
• Ferroptosis crosstalk: ACSL4 links lipid metabolism to apoptotic and ferroptotic cell death.
• Transcription factors: AP-1 components regulate cell life and death decisions.
• Ubiquitin-proteasome system: Degradation of anti-apoptotic proteins promotes apoptosis.
• Alternative splicing: EndoG influences Caspase-2 splicing, impacting apoptotic commitment.
• Long non-coding RNAs: BRE-AS1 represses survival via NR4A3 upregulation.
• S100A4: Modulates proliferation and apoptosis in glioma.
• Therapeutic targeting: CRISPR screens identify positive regulators as drug targets [1, 6].
What Happens During positive regulation of apoptotic process?
Initiation of Apoptotic Signaling
In simple terms: The cell receives a signal to begin self-destruction.
Positive regulation of apoptosis can be initiated by extrinsic death receptor ligation or intrinsic cellular stress. Cytotoxic agents and developmental cues activate pro-apoptotic signaling cascades. Transcription factors such as AP-1 modulate the expression of genes that tip the balance toward death.
Mitochondrial Outer Membrane Permeabilization
In simple terms: Mitochondria release factors that commit the cell to die.
BCL-2 family proteins regulate mitochondrial outer membrane permeabilization (MOMP). Pro-apoptotic members such as BAX and BAK promote MOMP, leading to cytochrome c release and apoptosome formation. This step is a point of no return in many apoptotic pathways.
Caspase Activation Cascade
In simple terms: A chain of enzymes executes the death program.
Initiator caspases (e.g., caspase-9, caspase-8) activate executioner caspases (e.g., caspase-3, caspase-7). This cascade is tightly regulated by inhibitors and ubiquitin-proteasome-mediated degradation of anti-apoptotic proteins. EndoG can influence caspase-2 splicing, adding another layer of regulation.
Transcriptional and Post-transcriptional Control
In simple terms: Genes and RNAs adjust the sensitivity to death signals.
Transcription factors such as AP-1 and p53 upregulate pro-apoptotic genes. Long non-coding RNAs like BRE-AS1 can repress survival pathways by upregulating NR4A3. S100A4 expression is linked to apoptosis regulation in glioma.
Crosstalk with Other Cell Death Pathways
In simple terms: Apoptosis can be influenced by lipid metabolism and ferroptosis.
ACSL4, an acyl-CoA synthase, is essential for ferroptosis and fatty acid metabolism, and its activity can intersect with apoptotic signaling. This crosstalk expands the landscape of positive regulation of cell death.
Key Genes Involved in GO:0043065 positive regulation of apoptotic process
The following genes and proteins are experimentally validated participants in positive regulation of apoptotic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ACSL4 | Promotes ferroptosis and lipid metabolism; crosstalk with apoptosis | Target for cell death pathway studies |
| AP-1 (JUN/FOS) | Transcription factor regulating cell life and death | Modulates pro-apoptotic gene expression |
| Caspase-3 | Executioner caspase | Central to apoptotic execution |
| Caspase-9 | Initiator caspase in intrinsic pathway | Apoptosome component |
| BAX | Pro-apoptotic BCL-2 family member | MOMP regulator |
| BAK | Pro-apoptotic BCL-2 family member | MOMP regulator |
| NR4A3 | Upregulated by BRE-AS1; represses survival | Lung cancer cell growth inhibition |
| BRE-AS1 | Long non-coding RNA repressing survival | Non-small cell lung cancer model |
| S100A4 | Regulates proliferation, apoptosis, migration | Glioma progression marker |
| EndoG | Apoptotic endonuclease; induces Caspase-2 splicing | Alternative splicing regulation |
| Caspase-2 | Initiator caspase with splicing variants | Apoptotic commitment |
| p53 | Transcription factor inducing pro-apoptotic genes | Cytotoxic response |
| BCL-2 | Anti-apoptotic; its degradation promotes apoptosis | Ubiquitin-proteasome target |
| MCL-1 | Anti-apoptotic; degradation promotes apoptosis | Ubiquitin-proteasome target |
| XIAP | Inhibitor of apoptosis; ubiquitination regulates | Caspase inhibition |
| Cytochrome c | Released from mitochondria; activates apoptosome | MOMP readout |
| Apaf-1 | Apoptosome scaffold | Caspase-9 activation |
How Is positive regulation of apoptotic process Regulated?
Positive regulation of apoptotic process is controlled at multiple levels. The ubiquitin-proteasome system degrades anti-apoptotic proteins such as BCL-2 and MCL-1, thereby promoting apoptosis. Transcriptional regulation by AP-1 and p53 modulates the expression of pro- and anti-apoptotic genes [2, 3]. Non-coding RNAs, such as BRE-AS1, can upregulate pro-apoptotic factors like NR4A3. Additionally, alternative splicing of Caspase-2 by EndoG adds a layer of post-transcriptional control. Crosstalk with lipid metabolism via ACSL4 influences ferroptosis, which can intersect with apoptotic pathways.
positive regulation of apoptotic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ACSL4 | Ferroptosis and fatty acid metabolism | CRISPR knockout in cancer cell lines |
| BRE-AS1 | Non-small cell lung cancer | Overexpression and knockout in NSCLC cells |
| S100A4 | Glioma progression | Knockdown/knockout in glioma cell lines |
| Caspase-2 | Apoptotic commitment; splicing variants | Point mutation of splice sites |
| BCL-2 | Apoptosis evasion in cancer | Knock-in of degradation-resistant mutant |
Cancer
Evasion of apoptosis is a hallmark of cancer. Positive regulators of apoptosis are often downregulated or mutated in tumors, leading to uncontrolled proliferation. For example, BRE-AS1 represses non-small cell lung cancer cell growth by upregulating NR4A3. S100A4 expression is linked to glioma progression and regulates apoptosis. Therapeutic strategies aim to restore apoptotic sensitivity.
Hematological Malignancies
Cytotoxic agents used in leukemia and lymphoma modulate apoptotic pathways. Positive and negative regulation of apoptosis by these agents determines treatment response. Understanding these mechanisms can guide combination therapies.
Neurodegeneration and Glioma
In glioma, S100A4 expression is closely linked to genesis and progression, regulating proliferation, apoptosis, migration, and invasion. Excessive apoptosis contributes to neuronal loss in neurodegenerative conditions, although the exact role of positive regulators requires further study.
Ferroptosis-Related Diseases
ACSL4 is an essential target in ferroptosis and fatty acid metabolism, with implications for diseases where lipid peroxidation and cell death crosstalk occur. This intersection expands the therapeutic landscape.
From positive regulation of apoptotic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X promote apoptosis? | CRISPR knockout cell line |
| Does a specific mutation alter pro-apoptotic activity? | Point mutation knock-in |
| Does overexpression of gene Y increase apoptosis? | Overexpression cell line |
| How does a tag affect protein localization during apoptosis? | Tagged knock-in |
| Which genes are essential for apoptosis? | Genome-wide CRISPR library screening |
| What are the transcriptomic changes during apoptosis? | RNA-seq of knockout vs wild-type |
How to Study the positive regulation of apoptotic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Annexin V flow cytometry | Phosphatidylserine externalization | Quantify apoptosis rate |
| Caspase-3/7 activity assay | Caspase enzymatic activity | Measure executioner caspase activation |
| RNA-seq | Transcriptome changes | Identify pro-apoptotic gene expression |
| Proteomics | Protein degradation and interactions | Study ubiquitin-proteasome regulation |
| CRISPR knockout screen | Gene essentiality for apoptosis | Discover positive regulators |
| Western blot | Protein cleavage (e.g., PARP) | Confirm apoptosis induction |
| TUNEL assay | DNA fragmentation | Detect apoptotic cells in situ |
Flow Cytometry
Annexin V/propidium iodide staining and caspase activity assays quantify apoptotic cells. This method is standard for measuring changes in positive regulation of apoptosis [3, 6].
Transcriptomics
RNA-seq can identify genes differentially expressed upon modulation of pro-apoptotic regulators, such as NR4A3 upregulation by BRE-AS1.
Proteomics and Ubiquitin Analysis
Mass spectrometry-based proteomics can assess degradation of anti-apoptotic proteins by the ubiquitin-proteasome system.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens identify positive regulators of apoptosis under specific stimuli, revealing novel therapeutic targets [1, 6].
How CRISPR Can Be Used to Study GO:0043065 positive regulation of apoptotic process
Knockout
CRISPR knockout of candidate pro-apoptotic genes (e.g., ACSL4, BAX) can determine whether they are required for apoptosis induction. This approach is widely used to validate positive regulators [1, 6].
Point Mutation
Introducing point mutations in genes such as Caspase-2 can dissect the role of specific residues or splice sites in apoptotic regulation.
Knock-in
Knock-in of tagged or mutant versions of anti-apoptotic proteins (e.g., BCL-2) allows tracking of their degradation and function during apoptosis.
Overexpression
Overexpression of pro-apoptotic genes like NR4A3 or BRE-AS1 can sensitize cancer cells to apoptosis, providing functional evidence for their role.
How EDITGENE Supports positive regulation of apoptotic process Research
Researchers studying positive regulation of apoptotic process-related genes often need to determine whether a candidate gene is causally involved in promoting cell death. EDITGENE provides CRISPR-based cell model services to enable precise functional validation.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of apoptotic process research.
Frequently Asked Questions About positive regulation of apoptotic process
What is GO:0043065 positive regulation of apoptotic process?
It is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of cell death by apoptotic process [1, 2, 3].
What genes are involved in positive regulation of apoptotic process?
Key genes include ACSL4, AP-1 components, caspases, BAX, BAK, NR4A3, BRE-AS1, S100A4, EndoG, and BCL-2 family members [1, 2, 4, 6, 7, 8].
How is positive regulation of apoptosis studied?
Common methods include flow cytometry, caspase activity assays, RNA-seq, proteomics, and CRISPR screens [3, 4, 6].
What diseases are linked to dysregulated apoptosis?
Cancer, hematological malignancies, glioma, and ferroptosis-related diseases [1, 3, 4, 8].
What is the role of ACSL4 in apoptosis?
ACSL4 is essential for ferroptosis and fatty acid metabolism, with crosstalk to apoptotic pathways.
How does AP-1 regulate apoptosis?
AP-1 transcription factors regulate cell life and death decisions by modulating pro- and anti-apoptotic gene expression.
Can CRISPR be used to study apoptosis regulators?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in apoptosis [1, 4, 6].
What is the role of the ubiquitin-proteasome system in apoptosis?
It degrades anti-apoptotic proteins like BCL-2 and MCL-1, thereby promoting apoptosis.
How does EndoG influence apoptosis?
EndoG is an apoptotic endonuclease that induces alternative splicing of Caspase-2, affecting apoptotic commitment.
What is the link between S100A4 and glioma?
S100A4 expression is closely linked to glioma genesis and progression by regulating proliferation, apoptosis, migration, and invasion.
Conclusion
GO:0043065 positive regulation of apoptotic process is a central biological process that integrates transcriptional, post-transcriptional, and post-translational control of cell death. Its dysregulation is implicated in cancer, neurodegeneration, and other diseases, making it a prime target for functional genomics. CRISPR-based models and screening approaches offer powerful tools to dissect the causal roles of individual genes and to identify novel therapeutic targets [1, 4, 6]. Continued research using these methods will advance our understanding of apoptosis regulation and its clinical applications.
References
- 1. Ding K et al.. 2023. Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism.. Chin Med J (Engl) 136(21):2521-2537 PMID: 37442770
- 2. Shaulian E et al.. 2002. AP-1 as a regulator of cell life and death.. Nat Cell Biol 4(5):E131-6 PMID: 11988758
- 3. Solary E et al.. 2000. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies.. Leukemia 14(10):1833-49 PMID: 11021759
- 4. Zhang M et al.. 2018. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3.. Arch Biochem Biophys 660:53-63 PMID: 30227111
- 6. Abbas R et al.. 2021. Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System.. Cells 10(12) PMID: 34943974
- 7. Zhdanov DD et al.. 2024. Apoptotic endonuclease EndoG induces alternative splicing of Caspase-2.. Biomed Khim 70(4):218-230 PMID: 39239896
- 8. Jin T et al.. 2015. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.. Asian Pac J Cancer Prev 16(7):2883-7 PMID: 25854377
